Biodesix, Inc.
NASDAQ:BDSX
1.39 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 26.384 | 43.088 | 32.712 | 62.126 | 5.286 | 5.914 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 26.384 | 43.088 | 32.712 | 62.126 | 5.286 | 5.914 |
| Net Receivables
| 7.679 | 5.065 | 3.656 | 15.304 | 5.292 | 1.892 |
| Inventory
| 1.4 | 1.4 | 2.9 | 3.2 | 0.8 | 0.7 |
| Other Current Assets
| 4.22 | 5.181 | 7.245 | 8.71 | 2.122 | 2.107 |
| Total Current Assets
| 39.683 | 53.334 | 43.613 | 86.14 | 12.7 | 9.913 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 29.612 | 8.821 | 4.179 | 3.178 | 2.12 | 1.388 |
| Goodwill
| 15.031 | 15.031 | 15.031 | 15.031 | 11.631 | 10.804 |
| Intangible Assets
| 7.911 | 9.797 | 11.617 | 13.26 | 15.092 | 16.853 |
| Goodwill and Intangible Assets
| 22.942 | 24.828 | 26.648 | 28.291 | 26.723 | 27.657 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 6.859 | 5.923 | 1.657 | 3.461 | 0.09 | 0.099 |
| Total Non-Current Assets
| 59.413 | 39.572 | 32.484 | 34.93 | 28.933 | 29.144 |
| Total Assets
| 99.096 | 92.906 | 76.097 | 121.07 | 41.633 | 39.057 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 2.929 | 1.685 | 1.662 | 8.964 | 1.717 | 0.886 |
| Short Term Debt
| 0.303 | 1.592 | 0.019 | 11.84 | 12.159 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0.324 | 0.962 | 1.85 | 3.532 | 1.283 | 0.492 |
| Other Current Liabilities
| 29.86 | 18.6 | 25.429 | 7.789 | 7.441 | 3.09 |
| Total Current Liabilities
| 33.416 | 22.839 | 28.96 | 32.125 | 22.6 | 4.468 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 35.225 | 30.258 | 9.993 | 15.926 | 23.812 | 23.099 |
| Deferred Revenue Non-Current
| 0.3 | 0.4 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 25.163 | -0.4 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.412 | 19.203 | 17.417 | 31.853 | 223.76 | 209.52 |
| Total Non-Current Liabilities
| 61.1 | 49.461 | 27.41 | 47.779 | 247.572 | 232.619 |
| Total Liabilities
| 94.516 | 72.3 | 56.37 | 79.904 | 270.172 | 237.087 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 121.07 | 193.959 | 183.962 |
| Common Stock
| 0.096 | 0.078 | 0.031 | 0.027 | 0.001 | 0.001 |
| Retained Earnings
| -419.566 | -367.42 | -301.973 | -258.814 | -230.864 | -200.138 |
| Accumulated Other Comprehensive Income/Loss
| -0 | 0 | 0 | -121.07 | -193.959 | -5.568 |
| Other Total Stockholders Equity
| 424.05 | 387.948 | 321.669 | 299.953 | 2.324 | -176.287 |
| Total Shareholders Equity
| 4.58 | 20.606 | 19.727 | 41.166 | -228.539 | -198.03 |
| Total Equity
| 4.58 | 20.606 | 19.727 | 41.166 | -228.539 | -198.03 |
| Total Liabilities & Shareholders Equity
| 99.096 | 92.906 | 76.097 | 121.07 | 41.633 | 39.057 |